Kalaris Therapeutics (KLRS) Receivables - Other (2019 - 2024)
Kalaris Therapeutics (KLRS) posted Receivables - Other of $169,000 for Q3 2020, down 52.3% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Receivables - Other (2019 - 2024) Analysis & Trends
At the end of FY2019, Kalaris Therapeutics' Receivables - Other came in at $298,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2020 | 298,000.00 |
| Sep 30, 2020 | 169,000.00 |
| Jun 30, 2020 | 354,000.00 |
| Mar 31, 2020 | -48,000.00 |
| Dec 31, 2019 | 298,000.00 |
API Access
Kalaris Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();